冰敷用于术后疼痛:一项随机对照试验
该随机对照试验在两家学术三级医疗中心纳入计划行门诊腹腔镜子宫切除术的患者,比较标准加速康复外科疼痛管理联合或不联合冰敷的效果。结果显示两组吗啡毫克当量需求无差异(P=0.63),术后第1天视觉模拟量表评分无差异(P=0.89);87%的干预组受试者表示会再次使用冰敷,82.6%表示会向他人推荐冰敷,无冰敷相关不良事件。结论认为冰敷是可接受的辅助镇痛措施,但未减少术后疼痛或阿片类药物用量。
要点
- 冰敷作为腹腔镜子宫切除术后标准疼痛管理的辅助措施,未降低术后疼痛评分或阿片类药物用量。
- 两组吗啡毫克当量需求无差异(P=0.63),术后第1天视觉模拟量表评分无差异(P=0.89)。
- 87%的干预组受试者表示会再次使用冰敷,82.6%表示会向他人推荐冰敷,无冰敷相关不良事件。
核心结论
- 冰敷是可接受的术后疼痛控制辅助措施,但与不联合冰敷的标准疼痛管理相比,未减少术后疼痛或阿片类药物用量。
研究设计与样本
- 经机构审查委员会批准的随机对照试验,受试者为因良性疾病行腹腔镜子宫切除术的患者,随机接受标准加速康复外科疼痛管理或标准加速康复外科疼痛管理联合冰敷。
- 研究在两家学术三级医疗中心进行,2019年2月至2020年11月期间由微创妇科手术团队考虑纳入计划行门诊腹腔镜子宫切除术的患者。
- 排除慢性疼痛、当前阿片类药物使用≥1周或计划过夜住院的患者;主要结局数据共51例受试者(对照组24例,干预组27例)。
- 干预措施为在手术室将冰袋置于腹部。
主要发现
- 两组在任何人口学变量上均无差异。
- 两组吗啡毫克当量需求无差异(P=0.63)。
- 术后第1天视觉模拟量表评分无差异(P=0.89)。
- 85%的受试者报告感觉疼痛得到控制;报告疼痛未得到控制的受试者在术后第1天未使用更多阿片类药物(P=0.37),术后第1天视觉模拟量表评分也未更高(P=0.55)。
- 87%的干预组受试者表示会再次使用冰敷,82.6%表示会向他人推荐冰敷;无冰敷相关不良事件;所有受试者均被处方20片羟考酮,出院后平均使用2.9片(标准差3.4)。
临床怎么用
- 原文结论认为冰敷是可接受的术后疼痛控制辅助措施,但未减少术后疼痛或阿片类药物用量;原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate the benefit of ice packs as a supplement to standard pain management following laparoscopic hysterectomy (LH). DESIGN: This Institutional Review Board-approved randomized controlled trial involved patients undergoing LH for benign conditions. Subjects were randomized to receive standard enhanced recovery after surgery pain management or standard enhanced recovery after surgery plus ice packs. SETTING: Two academic tertiary care centers PATIENTS: Patients undergoing planned outpatient LH with the minimally invasive gynecologic surgery team between February 2019 and November 2020 were considered. Patients with chronic pain, current opioid use ≥1 week, or planned overnight hospitalizations were excluded. Primary outcome data were available for 51 subjects (24 control, 27 intervention). INTERVENTIONS: Ice packs were placed on the abdomen in the operating room. MEASUREMENTS AND MAIN RESULTS: Pain was assessed at multiple time points throughout the study using a visual analogue scale (VAS). Opioid requirement was assessed using morphine milligram equivalent. There was no difference between the groups on any demographic variables. Morphine milligram equivalent requirements were also not different between the groups (p = .63). Postoperative day 1 (POD#1) VAS scores were not different (p = .89). Eighty-five percent of subjects reported feeling that their pain was controlled. Subjects who reported that they did not feel their pain was controlled did not use more opioids on POD#1 (p = .37), nor did they have higher POD#1 VAS scores (p = .55). Eighty-seven percent of the intervention subjects said they would use ice again, and 82.6% of them said they would recommend ice to others. There were no adverse events related to ice. All subjects were prescribed 20 tablets oxycodone and averaged 2.9 (SD 3.4) tablets used after discharge. CONCLUSION: Ice packs are an acceptable supplement for postoperative pain control, but they do not reduce postoperative pain or opioid usage compared to standard pain management without ice packs.
引用
- Shields JK, Kenyon L, Porter A, et al. Ice-POP: Ice Packs for Postoperative Pain: A Randomized Controlled Trial. J Minim Invasive Gynecol. 2023. PMID: 36740018. doi:10.1016/j.jmig.2023.01.015
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。